Skip to main content
. Author manuscript; available in PMC: 2018 Sep 24.
Published in final edited form as: AIDS. 2017 Sep 24;31(15):2077–2084. doi: 10.1097/QAD.0000000000001589

Table 1. Demographics and baseline characteristics.

Cohort Characteristics (non-viral). IV drug history and history of an AIDS-defining illness were recorded, but did not differ significantly among the three strata.

HIV VL >1000 ≤1000 any
CD4 ≤200 ≤200 CD4 >200
Characteristic A (N=157) B (N=91) C/D (N=59) Total (N=307) P-Value
Sex M 87 (55%) 77 (85%) 40 (68%) 204 (66%) <.001*
F 70 (45%) 14 (15%) 19 (32%) 103 (34%)
Location US 58 (37%) 83 (91%) 59 (100%) 200 <.001*
Haiti 99 (63%) 8 (9%) 0 (0%) 107
Race/Ethnicity White non-Latino 8 (5%) 28 (31%) 13 (22%) 49 (16%) <.001*
Black non-Latino 138 (88%) 55 (60%) 28 (47%) 221 (72%)
Latino (regardless of race) 7 (4%) 8 (9%) 15 (25%) 30 (10%)
Other 4 (3%) 0 (0%) 3 (5%) 7 (2%)
Oral Candidiasis No 51 (32%) 72 (79%) 51 (86%) 174 (57%) <.001*
Yes 104 (66%) 16 (18%) 8 (14%) 128 (42%)
Missing 2 (1%) 3 (3%) 0 (0%) 5 (2%)
Oral Hairy Leukoplakia No 133 (85%) 83 (91%) 49 (83%) 265 (86%) .047*
Yes 24 (15%) 5 (5%) 10 (17%) 39 (13%)
Missing 0 (0%) 3 (3%) 0 (0%) 3 (1%)
Kaposi Sarcoma No 128 (82%) 86 (95%) 59 (100%) 273 (89%) <.001*
Yes 29 (18%) 2 (2%) 0 (0%) 31 (10%)
Missing 0 (0%) 3 (3%) 0 (0%) 3 (1%)
Currently on ART? No 75 (48%) 2 (2%) 22 (37%) 99 (32%) <.001*
Yes 82 (52%) 89 (98%) 37 (63%) 208 (68%)
Age at study entry N 157 91 59 307 <.001**
Median 42 48 43 44
Q1, Q3 37, 50 43, 54 34, 49 38, 51
CD4 (cells/μL) N 157 88 59 304 <.001**
Missing 0 3 0 3
Median 93 142 525 138
Q1, Q3 38, 143 100, 172 339, 657 71, 189
Log10[HIV RNA(cp/ml)] N 157 88 59 304 <.001**
Missing No. 0 3 0 3
Median 5.12 1.70 1.88 4.40
Q1, Q3 4.70, 5.53 1.60, 1.89 1.68, 4.43 1.70, 5.18
Colony Unit Count (CFU/ml) N 155 88 59 302 <.001**
Missing 2 3 0 5
Median 1,660 100 200 720
Q1, Q3 400, 2,800 1, 1,223 1, 980 8, 2,360
*

Fisher’s Exact Test

**

Kruskal-Wallis Test